May 6, 2015
On Monday, April 27, SNMMI held it's annual Capitol Hill Day. This year there were 45 participants who met with 62 congressional offices representing 20 states. The following are the main topics that were discussed:
- A Reliable Domestic Supply of Molybdenum-99 (Mo-99): While the United States uses 50 percent of the world’s Mo-99, our supply comes from reactors in other countries, primarily Canada and the Netherlands. However, the Canadian facility will be phased out of commercial isotope production beginning in 2018. Additionally, in 2012, Congress enacted the American Medical Isotopes Production Act (AMIPA) of 2011, which requires industry to convert its technology from highly enriched uranium (HEU) to non-HEU.
- Appropriate Reimbursement for Radiopharmaceuticals: Every year, millions of Americans are diagnosed and/or treated using nuclear medicine and molecular imaging. The Centers for Medicare and Medicaid Services (CMS) currently sets Medicare hospital payment rates for nuclear medicine procedures and radiopharmaceutical drugs that often do not cover the provider costs of all diagnostic radiopharmaceuticals. This lack of coverage threatens patient access to care and Congress needs to make sure that CMS appropriately pays for all diagnostic radiopharmaceuticals.
SNMMI’s 2015 Capitol Hill Day was a great success! Advocacy is an ongoing effort that is strengthened by the connections made between SNMMI members and their congressional representatives. We thank everyone who took time out from their busy schedules to participate.